How Livestock Growth and Zoonotic Awareness Are Powering the Global Animal Vaccine Market to USD 38.7 Billion by 2035

The animal vaccine market was valued at $13.5 billion in 2024 and is projected to reach $38.7 billion by 2035, growing at a CAGR of 10.1% during the forecast period (2025-2035). The global animal vaccine market is experiencing strong growth as rising demand for animal protein drives intensified livestock production worldwide. Increasing awareness of zoonotic diseases and their link to public health is pushing governments and producers to prioritize vaccination programs for both livestock and companion animals.

Browse the full report description of  ”Animal Vaccine Market Size, Share & Trends Analysis by Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines), and by Technology (Live Attenuated Vaccines, Killed/Inactivated Vaccine, Recombinant Vaccines, and Other) Forecast Period (2025-2035)” of https://www.omrglobal.com/industry-reports/animal-vaccine-market

Technological innovations, including recombinant vaccines, mRNA platforms, and improved cold-chain distribution, are enhancing vaccine efficacy and accessibility. Moreover, regulatory pressure and advancements in supply-chain management are helping streamline production and ensure timely delivery to emerging and established markets.

Market Developments Highlighting Industry Momentum

• 2025: Rising outbreaks of avian influenza and swine fever in Asia-Pacific prompted accelerated vaccination campaigns, boosting market uptake.
• 2024-2025:S. and EU governments increased regulatory focus on zoonotic disease prevention, supporting the adoption of advanced animal vaccines.
• 2025: Advanced vaccine formulations, including combination vaccines and recombinant technologies, were adopted by leading manufacturers to improve herd immunity and streamline vaccination programs.

Industry Innovation and Adoption Trends

Key players are expanding R&D efforts to develop next-generation vaccines and scalable manufacturing processes. Companies are also leveraging partnerships with veterinary organizations and livestock integrators to enhance market penetration and meet growing biosecurity demands globally.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
• Type
• Technology

• Competitive Landscape – Boehringer Ingelheim International GmbH, Ceva Santé Animale, Elanco Animal Health Inc., Merck Animal Health and Zoetis Inc.

 Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

 Global Animal Vaccine Market Report Segment

By Type

• Porcine Vaccines
• Poultry Vaccines
• Livestock Vaccines
• Aquaculture Vaccines
• Companion Animal Vaccines
• Other Animal Vaccines

By Technology

• Live Attenuated Vaccines
• Killed/Inactivated Vaccine
• Recombinant Vaccines
• Other

Global Animal Vaccine Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/animal-vaccine-market